Granulocyte-colony stimulating factor increases CD123hi blood dendritic cells with altered CD62L and CCR7 expression
about
Either interleukin-12 or interferon-gamma can correct the dendritic cell defect induced by transforming growth factor beta in patients with myeloma.Immunological effects of vaccines combined with granulocyte colony-stimulating factor on a murine WEHI-3 leukemia model.Cyclophosphamide induces bone marrow to yield higher numbers of precursor dendritic cells in vitro capable of functional antigen presentation to T cells in vivo.Effects of pegylated G-CSF on immune cell number and function in patients with gynecological malignanciesCyclophosphamide induces dynamic alterations in the host microenvironments resulting in a Flt3 ligand-dependent expansion of dendritic cells.Recovery from cyclophosphamide-induced lymphopenia results in expansion of immature dendritic cells which can mediate enhanced prime-boost vaccination antitumor responses in vivo when stimulated with the TLR3 agonist poly(I:C)Dendritic cell recovery post-lymphodepletion: a potential mechanism for anti-cancer adoptive T cell therapy and vaccinationHuman dendritic cells and transplant outcome.The chemokine system in allogeneic stem-cell transplantation: a possible therapeutic target?Granulocyte colony-stimulating factor impairs CD8(+) T cell functionality by interfering with central activation elements.Nanoparticles modify dendritic cell homeostasis and induce non-specific effects on immunity to malaria.Kinetics of rebounding of lymphoid and myeloid cells in mouse peripheral blood, spleen and bone marrow after treatment with cyclophosphamide.Chemotherapy plus G-CSF mobilized peripheral blood stem cell harvests from acute myeloid leukaemia patients contain large amounts of polyclonal myeloid linnegCD11cpos dendritic precursor cells.The sphingosine-1-phosphate receptor agonist FTY720 modulates dendritic cell trafficking in vivo.Dendritic Cell-Based Immunotherapy
P2860
Q33203486-65CBAD43-4E1C-41B9-BA5F-A2CE816BAD2CQ33597774-E1106E35-303F-4837-A0AA-3F2D7E001725Q33653210-F28667F1-821C-41A2-BE66-392BBC450E94Q34353567-525F8DF0-B0B1-40D8-B01E-E04381FA9CAEQ34732294-2386D9AB-8DB3-4695-BDF4-BCE6FCF82FB8Q34732473-AE6FFA82-D1FE-4A4B-A35C-287831BFD3C7Q34759603-828D0543-2C4A-4CC0-8EDE-0B13BC8B7F97Q37190393-4B293C98-DE6C-4BD7-A7E7-456EA9013BA5Q37937045-4A07D694-F943-4174-B181-B5369354654AQ38785195-8805A265-0C56-478B-AA79-9EA51AAE5D14Q41554436-8CFE8265-43AE-494E-8C23-F1C79A5FDD34Q42113273-4A87E8BB-A9A0-4548-A15F-ADDF5AE8C24BQ44761444-8D2AA3E1-D416-4F0A-ADF2-FCE35C8488FFQ46741854-8360C963-7E2D-4682-8472-2A5F7560CD6EQ58409682-14D1BD9D-C566-4B22-9D23-B7CC9DAE2F9A
P2860
Granulocyte-colony stimulating factor increases CD123hi blood dendritic cells with altered CD62L and CCR7 expression
description
im Oktober 2002 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 24 October 2002
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в жовтні 2002
@uk
name
Granulocyte-colony stimulating ...... ered CD62L and CCR7 expression
@en
Granulocyte-colony stimulating ...... ered CD62L and CCR7 expression
@nl
type
label
Granulocyte-colony stimulating ...... ered CD62L and CCR7 expression
@en
Granulocyte-colony stimulating ...... ered CD62L and CCR7 expression
@nl
prefLabel
Granulocyte-colony stimulating ...... ered CD62L and CCR7 expression
@en
Granulocyte-colony stimulating ...... ered CD62L and CCR7 expression
@nl
P2093
P1433
P1476
Granulocyte-colony stimulating ...... ered CD62L and CCR7 expression
@en
P2093
Cameron J Turtle
Cathryn Kelly
Dailal Khalil
Derek N J Hart
Devinder Gill
Georgina V Crosbie
Katrina Williams
Ken Bradstock
Kerry Taylor
P304
P356
10.1182/BLOOD-2002-03-0973
P407
P577
2002-10-24T00:00:00Z